Related Experiment Video
Updated: Jul 8, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.1K
An effective Alzheimer's disease segmentation and classification using Deep ResUnet and Efficientnet
Battula Srinivasa Rao1, Mudiyala Aparna1, Jonnadula Harikiran1
1School of Computer Science and Engineering, VIT-AP University, Amravathi, India.
Journal of Biomolecular Structure & Dynamics
|December 20, 2023
Summary
This study presents an advanced AI system for early Alzheimer's disease (AD) detection using MRI scans. The novel method achieves high accuracy in categorizing AD stages, improving diagnostic capabilities.
Area of Science:
- Neurology
- Medical Imaging
- Artificial Intelligence
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive brain cell impairment and cognitive decline.
- Early diagnosis of AD is critical for effective patient care and treatment, yet conventional methods face limitations.
- Advanced image analysis techniques are needed for accurate and early AD detection.
Purpose of the Study:
- To develop an accurate and efficient system for Alzheimer's disease (AD) identification using magnetic resonance imaging (MRI).
- To leverage deep learning and advanced feature extraction for improved AD diagnosis.
- To categorize the stages of Alzheimer's disease with high precision.
Main Methods:
- Brain MRI images were segmented using a Deep ResUnet-based approach.
- Global and local features were extracted via a Multi-Scale Attention Siamese Network (MASNet).
- The Slime Mould Algorithm was employed for feature selection, followed by classification using EfficientNetB7.
Main Results:
- The proposed method achieved high accuracy in Alzheimer's disease (AD) categorization.
- Tested on Kaggle and ADNI datasets, the system demonstrated accuracies of 99.31% and 99.38%, respectively.
- The results indicate the system's effectiveness for accurate AD staging.
Conclusions:
- The developed AI-driven system offers a highly accurate and efficient approach for Alzheimer's disease (AD) diagnosis.
- This method shows significant potential for enhancing early detection and patient management in clinical settings.
- The study highlights the utility of integrated deep learning techniques for neurodegenerative disease classification.
Related Concept Videos
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492

